IN2014MN02126A - - Google Patents
Info
- Publication number
- IN2014MN02126A IN2014MN02126A IN2126MUN2014A IN2014MN02126A IN 2014MN02126 A IN2014MN02126 A IN 2014MN02126A IN 2126MUN2014 A IN2126MUN2014 A IN 2126MUN2014A IN 2014MN02126 A IN2014MN02126 A IN 2014MN02126A
- Authority
- IN
- India
- Prior art keywords
- compounds
- calcium
- crac
- channel
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN2126MUN2014 IN2014MN02126A (de) | 2012-05-02 | 2013-05-01 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN6KO2012 | 2012-05-02 | ||
IN2126MUN2014 IN2014MN02126A (de) | 2012-05-02 | 2013-05-01 | |
PCT/IB2013/053440 WO2013164769A1 (en) | 2012-05-02 | 2013-05-01 | Substituted pyridine compounds as crac modulators |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014MN02126A true IN2014MN02126A (de) | 2015-09-11 |
Family
ID=48428565
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN2126MUN2014 IN2014MN02126A (de) | 2012-05-02 | 2013-05-01 |
Country Status (7)
Country | Link |
---|---|
US (2) | US9399638B2 (de) |
EP (1) | EP2844655A1 (de) |
AU (1) | AU2013255437A1 (de) |
CA (1) | CA2871270A1 (de) |
IN (1) | IN2014MN02126A (de) |
WO (1) | WO2013164769A1 (de) |
ZA (1) | ZA201407685B (de) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10703722B2 (en) | 2010-04-27 | 2020-07-07 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
US9242969B2 (en) | 2013-03-14 | 2016-01-26 | Novartis Ag | Biaryl amide compounds as kinase inhibitors |
US9725463B2 (en) | 2013-06-21 | 2017-08-08 | Lupin Limited | Substituted heterocyclic compounds as CRAC modulators |
WO2014207648A1 (en) | 2013-06-24 | 2014-12-31 | Lupin Limited | Chromane and chromene derivatives and their use as crac modulators |
WO2015090579A1 (en) * | 2013-12-18 | 2015-06-25 | Grünenthal GmbH | Pyrazolyl-based carboxamides iv |
CN105367547B (zh) * | 2014-08-19 | 2019-04-23 | 北京桦冠生物技术有限公司 | 一种噁唑啉酮抗生素的新合成工艺 |
UY36294A (es) | 2014-09-12 | 2016-04-29 | Novartis Ag | Compuestos y composiciones como inhibidores de quinasa |
US10525021B2 (en) | 2014-11-18 | 2020-01-07 | Rutgers, The State University Of New Jersey | Mitochondrial uncouplers for treatment of metabolic diseases and cancer |
WO2016138472A1 (en) | 2015-02-27 | 2016-09-01 | Calcimedica, Inc. | Pancreatitis treatment |
CN107847548B (zh) | 2015-05-18 | 2022-06-14 | 贝思以色列女会吏医学中心公司 | P物质、肥大细胞脱颗粒抑制剂和周围神经病 |
CA2988147C (en) | 2015-06-03 | 2023-06-13 | Bristol-Myers Squibb Company | 4-hydroxy-3-(heteroaryl)pyridine-2-one apj agonists for use in the treatment of cardiovascular disorders |
JP6738575B2 (ja) | 2015-08-07 | 2020-08-12 | カルシメディカ,インク. | 脳卒中および外傷性脳損傷の処置のためのcracチャネル阻害剤の使用 |
CN109415363B (zh) | 2016-05-18 | 2021-07-20 | 罗格斯,新泽西州立大学 | 用于治疗代谢疾病和癌症的新的线粒体解偶联剂 |
MX2020006613A (es) * | 2017-12-22 | 2020-11-13 | Ravenna Pharmaceuticals Inc | Derivados de aril-bipiridina amina como inhibidores de fosfatidilinositol fosfato cinasa. |
PT3762368T (pt) | 2018-03-08 | 2022-05-06 | Incyte Corp | Compostos de aminopirazina diol como inibidores de pi3k-y |
WO2020010003A1 (en) | 2018-07-02 | 2020-01-09 | Incyte Corporation | AMINOPYRAZINE DERIVATIVES AS PI3K-γ INHIBITORS |
CA3112907A1 (en) | 2018-09-14 | 2020-03-19 | Rhizen Pharmaceuticals Ag | Compositions comprising a crac inhibitor and a corticosteroid and methods of use thereof |
CN110407740A (zh) * | 2019-09-04 | 2019-11-05 | 上海毕得医药科技有限公司 | 一种3-溴-2-乙基吡啶的合成方法 |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0412257A (pt) | 2003-07-23 | 2006-10-03 | Synta Pharmaceuticals Corp | compostos para inflamação e usos imuno-relacionados |
CN101083985A (zh) | 2004-09-21 | 2007-12-05 | 幸讬制药公司 | 用于炎症及免疫相关用途的化合物 |
US8202999B2 (en) | 2005-01-07 | 2012-06-19 | Synta Pharmaceuticals Corp. | Compounds for inflammation and immune-related uses |
ZA200707125B (en) | 2005-01-25 | 2008-11-26 | Synta Pharmaceuticals Corp | Compounds for inflammation and immune-related uses |
CA2595000C (en) | 2005-01-25 | 2013-10-15 | Synta Pharmaceuticals Corp. | Thiophene compounds for inflammation and immune-related uses |
CA2639927A1 (en) | 2006-01-25 | 2007-08-02 | Synta Pharmaceuticals Corp. | Substituted biaryl compounds for inflammation and immune-related uses |
EP1983971A4 (de) | 2006-01-25 | 2010-11-24 | Synta Pharmaceuticals Corp | Substituierte aromatische verbindungen für entzündungs- und immunbedingte verwendung |
CA2639913A1 (en) | 2006-01-25 | 2007-08-02 | Synta Pharmaceutical Corp. | Phenyl and pyridyl compounds for inflammation and immune-related uses |
WO2007089904A2 (en) | 2006-01-31 | 2007-08-09 | Synta Pharmaceuticals Corp. | Pyridylphenyl compounds for inflammation and immune-related uses |
EP2069359B1 (de) | 2006-08-21 | 2014-11-12 | Genentech, Inc. | Aza-benzothiophenylverbindungen und anwendungsverfahren dafür |
CA2695148A1 (en) | 2007-08-01 | 2009-02-05 | Synta Pharmaceuticals Corp. | Pyridine compounds for inflammation and immune-related uses |
KR101541558B1 (ko) | 2007-08-17 | 2015-08-03 | 액테리온 파마슈티칼 리미티드 | S1p1/edg1 수용체 조절제로서의 피리딘 유도체 |
JP5411141B2 (ja) | 2007-09-10 | 2014-02-12 | カルシメディカ,インク. | 細胞内カルシウムを調節する化合物 |
US8389567B2 (en) | 2007-12-12 | 2013-03-05 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
EA018817B1 (ru) | 2008-05-23 | 2013-10-30 | Глэксо Груп Лимитед | Трициклические азотсодержащие соединения и их применение в качестве бактерицидных средств |
DE102008031299B4 (de) | 2008-07-02 | 2014-10-30 | Acandis Gmbh & Co. Kg | Filter für ein Blutgefäß |
WO2010027875A2 (en) | 2008-08-27 | 2010-03-11 | Calcimedica Inc. | Compounds that modulate intracellular calcium |
US8524763B2 (en) | 2008-09-22 | 2013-09-03 | Calcimedica, Inc. | Inhibitors of store operated calcium release |
TW201018667A (en) | 2008-10-01 | 2010-05-16 | Synta Pharmaceuticals Corp | Compounds for inflammation and immune-related uses |
UY32856A (es) | 2009-08-26 | 2011-03-31 | Astrazeneca Ab | Derivados heterocíclicos de urea y métodos de uso de los mismos |
WO2011034962A2 (en) | 2009-09-16 | 2011-03-24 | Calcimedica Inc. | Compounds that modulate intracellular calcium |
RS54870B1 (sr) | 2010-10-30 | 2016-10-31 | Lupin Ltd | Derivati oksazolina i izoksazolina kao crac modulatori |
JP5985611B2 (ja) | 2011-05-03 | 2016-09-06 | シンタ ファーマシューティカルズ コーポレーション | 炎症および免疫関連用途のための化合物 |
WO2013059677A1 (en) | 2011-10-19 | 2013-04-25 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
AU2012325901A1 (en) | 2011-10-19 | 2014-05-15 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
-
2013
- 2013-05-01 WO PCT/IB2013/053440 patent/WO2013164769A1/en active Application Filing
- 2013-05-01 EP EP13722111.5A patent/EP2844655A1/de not_active Withdrawn
- 2013-05-01 IN IN2126MUN2014 patent/IN2014MN02126A/en unknown
- 2013-05-01 CA CA2871270A patent/CA2871270A1/en not_active Abandoned
- 2013-05-01 AU AU2013255437A patent/AU2013255437A1/en not_active Abandoned
- 2013-05-01 US US14/398,154 patent/US9399638B2/en not_active Expired - Fee Related
-
2014
- 2014-10-22 ZA ZA2014/07685A patent/ZA201407685B/en unknown
-
2016
- 2016-06-20 US US15/186,882 patent/US20160304506A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20160304506A1 (en) | 2016-10-20 |
US9399638B2 (en) | 2016-07-26 |
AU2013255437A1 (en) | 2014-11-13 |
US20150111900A1 (en) | 2015-04-23 |
CA2871270A1 (en) | 2013-11-07 |
ZA201407685B (en) | 2015-11-25 |
EP2844655A1 (de) | 2015-03-11 |
WO2013164769A1 (en) | 2013-11-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2014MN02126A (de) | ||
IN2014MN02127A (de) | ||
CO6430427A2 (es) | Derivados de benzofuranilo | |
TN2013000348A1 (en) | Compounds and compositions as trk inhibitors | |
PH12015500551A1 (en) | Tricyclic quinoline and quinoline derivatives | |
GEP20166438B (en) | Imidazopyrrolidinone compounds | |
PH12014502757B1 (en) | Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases | |
CR20110103A (es) | Heteroarilos sustituidos | |
IN2014CN04907A (de) | ||
MX2015012478A (es) | Metodos y composiciones para inhibicion de proteinas que contienen bromodominio. | |
MD20140109A2 (ro) | Compuşi ai indolului şi indazolului care activează AMPK | |
IN2012DN00943A (de) | ||
WO2012170931A3 (en) | Compounds that modulate intracellular calcium | |
MX337711B (es) | Compuestos que modulan el calcio intracelular. | |
EA201200570A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
MY162689A (en) | Oxazoline and isoxazoline derivatives as crac modulators | |
TN2013000346A1 (en) | Asymmetric ureas and medical uses thereof | |
EA026940B9 (ru) | Замещенные хромановые соединения в качестве модуляторов чувствительного к кальцию рецептора | |
WO2012170951A3 (en) | Compounds that modulate intracellular calcium | |
TW201613878A (en) | Pyrazine GPR40 agonists for the treatment of type II diabetes | |
AU2011322715A8 (en) | Treatment of MeCP2-associated disorders | |
UY36081A (es) | Compuestos inhibidores de metaloenzima como fungicidas. | |
PH12014501979B1 (en) | Fused bicyclic 2,4-diaminopyrimidine derivative as a dual alk and fak inhibitor | |
IN2015MN00421A (de) | ||
MX357828B (es) | Composición con factores de crecimiento destinada al tratamiento intranasal de una enfermedad neurodegenerativa u otra patología del sistema nervioso central, y su método de fabricación. |